Evaluation of serum amyloid A and haptoglobin concentrations as prognostic indicators for horses with inflammatory disease examined at a tertiary care hospital.

The research investigates the use of serum amyloid A (SAA) and haptoglobin concentrations as possible predictive indicators for the prognosis of horses with inflammatory diseases, specifically looking at euthanasia rates, complications, and hospitalization duration and costs. It finds that these factors are not significantly correlated with outcomes at one single point of testing but may be more useful in a serial analysis approach.

Research Objectives and Methods

• The objective of the study was to assess if SAA and haptoglobin concentrations in horse blood serum could be used as prognostic indicators for horses suffering from inflammatory diseases. Prognostic indicators are parameters used to predict the likely progress or outcome of a disease.
• This was done by comparing the SAA and haptoglobin concentrations, along with standard clinical parameters, in normal horses and horses with inflammatory disease at the point of admission.
• The researchers also monitored the SAA and haptoglobin concentrations of 22 horses during their hospitalization to investigate the use of serial measurements in predicting result and complications.

Findings of the Study

• Inflammatory response markers, including neutrophil count and concentrations of SAA and haptoglobin, were significantly different in horses with inflammatory disease compared to normal horses at admission.
• Horses suffering from colitis and peritonitis had notably higher concentrations of SAA and haptoglobin compared to clinically normal horses.
• The researchers identified a moderate positive correlation between haptoglobin concentration and the duration of hospitalization.
• It was found that horses with an increase in SAA concentration between 24 and 72 hours after admission were significantly more likely to be euthanized or develop complications.

Conclusion and Implications

• The study concluded that SAA and haptoglobin concentration at admission had no significant correlation with the outcome in horses with inflammatory conditions. This indicates that a single time point analysis may not provide complete prognostic information.
• However, acute-phase protein analysis, in this case monitoring SAA and haptoglobin concentrations serially, rather than testing at a single point in time, could have utility in predicting disease outcomes and progress for horses with inflammatory conditions.
• This research could potentially provide veterinary clinicians with an additional tool for monitoring and predicting outcomes in equine patients with inflammatory diseases.